OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1648-1661
Open Access | Times Cited: 8
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1648-1661
Open Access | Times Cited: 8
Showing 8 citing articles:
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P. Coussens, Thomas S. Dexheimer, Thomas Silvers, et al.
SLAS DISCOVERY (2025), pp. 100230-100230
Open Access
Nathan P. Coussens, Thomas S. Dexheimer, Thomas Silvers, et al.
SLAS DISCOVERY (2025), pp. 100230-100230
Open Access
Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, et al.
SLAS DISCOVERY (2024), pp. 100186-100186
Open Access | Times Cited: 3
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, et al.
SLAS DISCOVERY (2024), pp. 100186-100186
Open Access | Times Cited: 3
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S. Dexheimer, Zahra Davoudi, Nathan P. Coussens, et al.
SLAS DISCOVERY (2025), pp. 100222-100222
Open Access
Thomas S. Dexheimer, Zahra Davoudi, Nathan P. Coussens, et al.
SLAS DISCOVERY (2025), pp. 100222-100222
Open Access
Polymerase Ѳ Inhibitors Combinations with Approved and Investigational Agents in Patient-Derived Tumor Multi-Cell Type (Mct) Spheroids
Beverly Ann Teicher, Thomas S. Dexheimer, Li Chen, et al.
(2025)
Closed Access
Beverly Ann Teicher, Thomas S. Dexheimer, Li Chen, et al.
(2025)
Closed Access
Revisiting Temozolomide's role in solid tumors: Old is gold?
Dimitrios Matthaios, Ioanna Balgkouranidou, Konstantinos Neanidis, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3254-3271
Open Access | Times Cited: 1
Dimitrios Matthaios, Ioanna Balgkouranidou, Konstantinos Neanidis, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3254-3271
Open Access | Times Cited: 1
Drug combinations with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P. Coussens, Thomas S. Dexheimer, Thomas Silvers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nathan P. Coussens, Thomas S. Dexheimer, Thomas Silvers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Therapeutic Targeting of ATR in Cancer
Ayten Haciefendi, Gamze Güney Eskiler
Interdisciplinary cancer research (2024)
Closed Access
Ayten Haciefendi, Gamze Güney Eskiler
Interdisciplinary cancer research (2024)
Closed Access
Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
